The roles and mechanism of VPS35 in tumorigenesis and metastasis
Article in Scientia Sinica Vitae (July 2023)
The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
Article in The Oncologist (June 2023)
Elucidating the potential effects of point mutations on FGFR3 inhibitor resistance via combined molecular dynamics simulation and community network analysis
Article in Journal of Computer-Aided Molecular Design (June 2023)